Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172011 · ClinicalTrials.gov registry record
Understanding the Long-term Impact of COVID on Children and Families
A clinical trial of SARS CoV 2 Infection, sponsored by NYU Langone Health.
- Active
- Registry status
- 15,028
- Enrollment target
- 20
- Study locations
NCT05172011: Active study of SARS CoV 2 Infection, sponsored by NYU Langone Health.
NCT05172011 is a study of SARS CoV 2 Infection that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 15,028 participants, above the 3,758-participant average among 35 other SARS CoV 2 Infection trials with a reported enrollment target (300% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05172011, a study of SARS CoV 2 Infection, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- 15,028 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals age 0-25 years who will enter the cohort with and without SARS-CoV-2 infection at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or without PASC symptoms will be followed to identify risk factors and occurrence of PASC. This study will be conducted in the United States and participants will be recruited through inpatient, outpatient, and community-based settings. Study data including age, demographics, social determinants of health, medical history, vaccination history, details of acute SARS-CoV-2 infection, overall health and physical function, and PASC symptoms will be reported by participants or collected from the electronic health record using a case report form at specified intervals. Biologic specimens will be collected at specified intervals, with some tests performed in local clinical laboratories and others performed by centralized research centers or banked in the Biospecimen Repository. Advanced clinical examinations and radiologic examinations will be performed at local study sites with cross-site standardization.
Primary Outcome
Initial SARS-CoV-2 infection is reported via remote patient report (electronic, paper or telephone assessments) and EHR. Infection categories include: SARS CoV 2 PCR result, SARS CoV 2 antigen result, SARS CoV 2 antibody result, SARS CoV 2 sequencing performed, diagnosed by a doctor based on symptoms, suspected by participant but not diagnosed by a doctor.
Conditions Studied
Study Locations (20)
California
- University of California San Diego - La Jolla
- Children's Hospital Los Angeles - Los Angeles
- University of California San Diego Health - Rady Children's Hospital - San Diego
- University of California San Francisco (Pregnancy Cohort) - San Francisco
- University of California San Francisco - San Francisco
Illinois
- Northwestern University - Evanston
- Northshore University HealthSystem - Glenview
- American Academy of Pediatrics - Itasca
Connecticut
- Connecticut Children's Medical Center - Hartford
- Yale School of Medicine (YSM) - New Haven
Delaware
- ChristianaCare Health System - Newark
- Nemours Children's Health - Wilmington
Louisiana
- Louisiana State University (LSU) - Pennington Biomedical Research Center - Baton Rouge
- Tulane University - New Orleans
Alabama
- University of Alabama at Birmingham (Pregnancy Cohort) - Birmingham
Arkansas
- Arkansas Children's Hospital and Research Institute - Little Rock
District of Columbia
- George Washington University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,028 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2027-05-23 |
What the registry record for NCT05172011 still lists
NCT05172011 is an observational study that tracks outcomes without assigning an intervention. Its 15,028 participants enrollment target places it among the larger protocols in the corpus, above the 3,758-participant average among 35 other SARS CoV 2 Infection trials with a reported enrollment target (300% higher).
The record links to 1 condition, with SARS CoV 2 Infection appearing as the primary indexed condition, and to 0 interventions.
NCT05172011 names 20 study sites across 11 states, led by California, Illinois, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05172011 about?
NCT05172011 is a clinical study titled "Understanding the Long-term Impact of COVID on Children and Families". This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals age 0-25 years who will enter the cohort with and without SARS-CoV-2 infection at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or without ...
What is the current status of trial NCT05172011?
This trial is currently active not recruiting. The enrollment target is 15,028 participants. The study started on 2022-03-01. Estimated completion is 2027-05-23.
What conditions does trial NCT05172011 study?
This clinical trial studies the following conditions: SARS CoV 2 Infection.
Who is sponsoring clinical trial NCT05172011?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05172011 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Connecticut, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SARS CoV 2 Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05172011's enrollment target sits among peer trials
15,028 4th of 35 higher than 32 of 35 other SARS CoV 2 Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other SARS CoV 2 Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise in Child Health
RECRUITING · NA
-
NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
RECRUITING
-
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
RECRUITING · NA
-
Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
RECRUITING · Phase 2
-
COVID-19 Transmission and Morbidity in Malawi
RECRUITING
-
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI